Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Relaxation Along a Fictitious Field, continuous wave T1rho, adiabatic T1rho and adiabatic T2rho imaging of human gliomas at 3T: A feasibility study.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • المصدر:
      Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: San Francisco, CA : Public Library of Science
    • الموضوع:
    • نبذة مختصرة :
      In pre-clinical models of brain gliomas, Relaxation Along a Fictitious Field in second rotating frame (TRAFF2), continues wave T1rho (T1ρcw), adiabatic T1rho (T1ρadiab), and adiabatic T2rho (T2ρadiab) relaxation time mappings have demonstrated potential to non-invasively characterize brain gliomas. Our aim was to evaluate the feasibility and potential of 4 different spin lock methods at 3T to characterize primary brain glioma. 22 patients (26-72 years) with suspected primary glioma. T1ρcw was performed using pulse peak amplitude of 500Hz and pulse train durations of 40 and 80 ms while the corresponding values for T1ρadiab, T2ρadiab, TRAFF2 were 500/500/500Hz and 48 and 96, 64 and 112, 45 and 90 ms, respectively. The parametric maps were calculated using a monoexponential model. Molecular profiles were evaluated from tissue specimens obtained during the resection. The lesion regions-of-interest were segmented from high intensity FLAIR using automatic segmentation with manual refinement. Statistical descriptors from the voxel intensity values inside each lesion and radiomic features (Pyrad MRC package) were calculated. From extracted radiomics, mRMRe R package version 2.1.0 was used to select 3 features in each modality for statistical comparisons. Of the 22 patients, 10 were found to have IDH-mutant gliomas and of those 5 patients had 1p/19q codeletion group comparisons. Following correction for effects of age and gender, at least one statistical descriptor was able to differentiate between IDH and 1p/19q codeletion status for all the parametric maps. In the radiomic analysis, corner-edge detector features with Harris-Stephens filtered signal showed significant group differences in IDH and 1p/19q codeletion groups. Spin lock imaging at 3T of human glioma was feasible and various qualitative parameters derived from the parametric maps were found to have potential to differentiate IDH and 1p19q codeletion status. Future larger prospective clinical trials are warranted to evaluate these methods further.
      Competing Interests: The authors have declared that no competing interests exist.
      (Copyright: © 2024 Jambor et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
    • References:
      Bioinformatics. 2013 Sep 15;29(18):2365-8. (PMID: 23825369)
      J Magn Reson. 2011 Apr;209(2):269-76. (PMID: 21334231)
      Magn Reson Med. 1999 Aug;42(2):268-76. (PMID: 10440951)
      Cancer Res. 2017 Nov 1;77(21):e104-e107. (PMID: 29092951)
      Clin Cancer Res. 2019 Dec 15;25(24):7455-7462. (PMID: 31548344)
      Neuro Oncol. 2021 Aug 2;23(8):1231-1251. (PMID: 34185076)
      Magn Reson Med. 2020 Jun;83(6):2293-2309. (PMID: 31703155)
      AJNR Am J Neuroradiol. 2003 Nov-Dec;24(10):1989-98. (PMID: 14625221)
      PLoS One. 2013 Apr 29;8(4):e61892. (PMID: 23658616)
      PLoS One. 2013 Jul 17;8(7):e69157. (PMID: 23874898)
      J Digit Imaging. 2023 Jun;36(3):911-922. (PMID: 36717518)
      Magn Reson Med. 2012 Jan;67(1):269-77. (PMID: 21721037)
      Magn Reson Med. 2016 Jan;75(1):337-44. (PMID: 25733132)
      Eur J Radiol. 2013 Sep;82(9):1512-8. (PMID: 23796882)
      Acad Radiol. 2024 Feb;31(2):660-683. (PMID: 37120403)
      Neurosurgery. 2021 Jul 15;89(2):177-184. (PMID: 33913492)
    • الرقم المعرف:
      EC 1.1.1.41 (Isocitrate Dehydrogenase)
    • الموضوع:
      Date Created: 20240401 Date Completed: 20240403 Latest Revision: 20240403
    • الموضوع:
      20240403
    • الرقم المعرف:
      PMC10984536
    • الرقم المعرف:
      10.1371/journal.pone.0296958
    • الرقم المعرف:
      38558074